Search results
An OrbiMed-backed biotech launches with $85M and plans for a new kind of DNA medicine
BioPharma Dive via Yahoo Finance· 8 months agoWhen developing new medicines, drugmakers typically try to make treatments that are more effective,...
Tr1x, a new biotech, joins ‘Treg’ chase with $75M fundraise
BioPharma Dive via Yahoo Finance· 5 months agoThe startup is focusing on immune cells called Tr1 cells, which it claims could be important in...
IntelGenx Technologies Corp. (PNK:IGXT) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoIntelGenx Technologies Corp. (PNK:IGXT) Q4 2022 Earnings Call Transcript March 29, 2023 Operator:...
Lack of diversity in clinical trials is leaving women and patients of color behind and harming the...
The Conversation via Yahoo News· 1 year agoMost clinical trials overrepresent young white males. Andresr/Digital Vision via Getty ImagesIts a...
2 Top Biotech Stocks to Buy for the Long Haul
Motley Fool· 2 years agoBiotech giants Amgen (NASDAQ: AMGN) and AstraZeneca (NASDAQ: AZN) are great options. In the second quarter, Amgen's revenue increased by an unimpressive...
4 Unparalleled Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
Motley Fool· 12 months agoIt's been a wild two years for Wall Street. After rocketing to record-closing highs in 2021, all...
